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ABSTRACT
Background: Traditionally known as Pashanabheda in India, Aerva lanata (L) belonging to the family Amaranthaceae, 
is widely available in Western ghats of India and used as Antiurolithiatic, astringent, diuretic, antimicrobial, anti-
inflammatory, hepatoprotective drug by Indian traditional system of medicines. Materials and Method: In the 
present study this herb is subjected to extraction with hydro alcohol followed by fractionation with different 
solvents of varying polarities such as dichloromethane, ethyl acetate and n-butanol and screened for Antiurolithiatic 
activity using ethylene glycol induced male Wistar albino rats. Based on the results, the potent fractions were 
subjected to isolation of active constituents using column chromatography. Results: The isolated compounds from 
two fractions n-butanol and ethyl acetate were characterized by modern analytical techniques such as IR, HPTLC, 
NMR and LCMS as Quercetin and Betulin. Later these two compounds were studied for Antiurolithiatic activity 
by In silico technique by docking with a protein 2 ETE of Oxalate oxidase from PDB and the results indicated 
better regio-specificity with the enzyme. Conclusion: The two compounds isolated from potent fractions based 
on bioactivity guided fractionation were characterized as Quercetin and Betulin by modern analytical techniques. 
These two compounds were studied by in silico method and these two compounds have produced significant 
results which substantiate their claim of bioactivity. However in vivo study is needed to confirm the activity.
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INTRODUCTION
Pashanabheda (stone dissolving) plants are a 
group of  medicinal plants which are used 
in Indian traditional medicinal system by 
Ayurvedic practitioners as Antiurolithiatic 
drugs. Traditionally Aerva lanata (Pashanab-
heda) is used as both Antiurolithiatic and 
diuretic.
The traditional medicines system is a rich 
source of  valuable medicinal plants but 
there is no scientific data to establish the 
activity of  these plants. These plants need 
to be evaluated, based on their biological 
efficacy and chemical constituents for the 
drug development. Hence we have selected 
Aerva lanata (L) which is traditionally used 
as Pashanabheda plant (stone dissolving) for 
Urolithiasis, available from Western Ghats 
region for our present study. Bioactivity 
guided fractionation of  this plant was car-
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ried out in order to investigate the tradi-
tional claim.
Many of  the medicinal plants available in 
India have not been studied scientifically 
for their activity till date. Also there is no 
spectral data available regarding the active 
constituents present in these plants which 
are responsible for their efficacy. Hence 
there is a need to identify active constitu-
ents of  these plants and screen them for 
their various activities to support their tra-
ditional claims. In this present study, Aerva 
lanata Linn. (Amaranthaceae) a herbaceous 
perennial weed which is available in the 
tropical regions and Western Ghats of  India 
is selected. The herb Aerva lanata commonly 
known as Pashanabheda has been claimed to 
be useful for its diuretic, anthelmintic, anti 
diabetic, expectorant, hepatoprotective, 
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antimicrobial, cytotoxic activity, antiurolithiatic  and 
anti-inflammatory activity.1,2
This plant is commonly used in Ayurvedic medicines 
and recommended in Ayurvedic texts for various dis-
eases. It is useful to treat boils, cephalalgia, cough and 
urolithiasis. The plant extract is proved for nephropro-
tective activity, diuretic effect, cytotoxicity and anti-
oxidant, immunomodulatory effect, diuretic effect, 
anti-inflammatory effect, antimicrobial activity, hepato-
protective activity, anti hyperglycemic effect.3,4
Although this plant is used traditionally by Ayurvedic 
physicians, however, there is no report on the spectral 
analysis of  different fractions of  Aerva lanata (L) till 
date. Also there is no report on the active constituents 
responsible for the biological activities claimed by the 
plant. Hence this plant available in Western Ghats of  
Khanapur region is selected for the study.
MATERIALS AND METHODS
Materials and Reagents
The whole plant Aerva lanata (L) is procured from 
Western Ghats region of  Khanapur Taluka, Belgaum 
for the study. It’s a herb widely available in this region. 
The plant is authenticated by taxonomist Dr. Harsha 
Hedge, Scientist B, RMRC, Belgaum (specification no-
RMRC-507). The whole plant is subjected to shade 
drying and then it was ground to coarse powder. The 
powdered dry material was used for the extraction 
with hydro alcohol. Aqueous extract was prepared by 
dissolving the dried hydro alcoholic extract in distilled 
water and the aqueous extract was partitioned with dif-
ferent solvents of  varying polarities [dichloromethane, 
ethyl acetate and n-butanol (S.D Fine chem. Ltd.)] in a 
separating funnel. The organic fractions were purified 
by washing with distilled water and treated with sodium 
sulphite overnight to remove moisture. These fractions 
were subjected to qualitative tests and chromatographic 
techniques.3
Animals
Male Wistar albino rats weighing 150-200 g were pur-
chased from Sri Venkateshwara traders, Bangalore. They 
were housed in acryl fiber cages at 23 ± 2oC, humid-
ity 50 ± 1% and were kept on a 12 h light/dark cycle. 
They were fed with standard chow feed (Amrut labo-
ratories, Sangali) and water ad libitum and acclimatized 
for 15 days before the study. Experimental protocols 
reported in this study were approved by the Institution 
Animal Ethical Committee of  CPCSEA, Govt. of  India 
(IAEC-Resolution No-13, 31-07-2010) and carried out 
in accordance with OECD guidelines.
Acute toxicity assay
Acute toxicity assay was performed as per OECD 
guidelines 423 (limit test). Six male Wistar albino rats 
(three animals in each step) were randomly selected. 
The animals were kept fasting for overnight providing 
only water. The extract was administered orally at one 
dose level of  2000 mg/kg b.wof  the animals. In further 
rats were observed continuously for the first 4 h and 
then periodically up to 24 h for toxic symptoms and 
mortality. The number of  deaths was noted to calculate 
LD50 and therapeutic dose.
Isolation 
These fractions (II and III) were subjected to screening 
for Antiurolithiatic activity using ethylene glycol (0.75%) 
(S.D. Fine. Chem. Ltd) induced Albino wistar male rats 
for 24 day study. The animals were divided into seven 
groups containing six each. The group I served as con-
trol and fed with normal rat food and water ad libitum. 
Group II to VII received ethylene glycol (0.75%) orally 
in drinking water from day 1 to day 28 for the induction 
of  renal calculi.  Group II served as disease induced 
group. Group III received standard drug Cystone (750 
mg/kg b.w) from 14th day to 28th day. Group IV 
received fraction II (20 mg/kg b.w.) group V received 
fraction II (40 mg/kg b.w), group VI received fraction 
III (20 mg/kg b.w.) and group VII received fraction III 
(40 mg/kg b.w) from 14th day to 28th day.4,5
The Phytochemical screening of  the extract and frac-
tions II and III showed mainly the presence of  flava-
noids, Saponins, Triterpenoids, glycosides, steroids and 
phenolic compounds. (Figure 1) 
No crystal deposition was found in normal group ani-
mals. Kidney section of  rats treated with ethylene glycol 
(0.75%) showed deposition of  micro crystals. There was 
tubular damage, infiltration of  inflammatory cells into 
the interstitial space. Kidney section of  animals treated 
with extract and fractions showed improvement of  the 
above symptoms and reduced crystal deposition.
Figure 1: UV spectrum of AEF 1
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Based on the biochemical and Histopathological results, 
these fractions were subjected to isolation of  potent 
compounds by using column chromatography tech-
nique followed by preparative TLC. The isolation tech-
nique has successfully isolated two compounds. These 
isolated compounds were subjected to characterization 
process by modern analytical techniques such as IR, 
HPTLC, 1HNMR, 13CNMR and LCMS.
The column (3.5×60 cm) was prepared with silica gel 
(60-120 mesh) in chloroform by wet method and col-
umn is put for overnight. Then the n-butanol fraction (5 
gm) was poured to silica gel open column chromatogra-
phy and step gradient technique was used to run the col-
umn. Various ratios of  Methanol-chloroform (1:10, 500 
ml; 1:5, 500 ml; 1:3, 500 ml; 1:2, 350 ml) were used for 
the isolation of  active component. The 20 fractions of  
20 ml each were collected; analyzed by TLC and same 
type of  fractions were mixed; then again analyzed by 
TLC and found that the aimed compound  is present 
as a single spot in the fraction collected from the 1:2 
solvent system and the Rf  value determined .
Similar method was used to isolate active compound/s 
from ethyl acetate fraction. Then the ethyl acetate frac-
tion (5 gm) was poured to silica gel open column and 
Various ratios of  Methanol-chloroform  (1:10, 500 ml; 
1:5, 500 ml; 1:3, 500 ml; 1:2, 350 ml) were used for the 
isolation of  active component (2). The fractions of  20 
ml were collected; analyzed by TLC and same type of  
fractions are mixed; then again analyzed by TLC and 
found that the aimed compound is present as a single 
spot in the fraction collected from the 1:2 solvent sys-
tem and the Rf  value determined. But in this step a com-
plex spot was observed in the TLC of  the combined 
fractions of  ethyl acetate. Later the complex spot was 
resolved into two spots with almost close Rf  values 0.53 
and 0.56. After isolation these three compounds were 
subjected to characterization by IR, HPTLC, NMR and 
LCMS. (Table 1-3)6-8
Instrumentation
The TLC spots were analyzed by Iodine chamber, the 
standard drugs Quercetin and Betulin used for com-
parison and Rf  values were determined. After TLC 
analysis, the compounds were studied by CAMAG 
HPTLC instrument for their qualitative analysis. 
Then the compounds were subjected to SHIMADZU 
FT-IR Spectrophotometer for identifying the probable 
functional groups present. After IR spectral analysis, 
the compounds were studied for 1HNMR using 400 
MHz BRUKER FT-NMR and 13CNMR by 100 MHz 
BRUKER FT-NMR Spectrophotometer for studying 
the Proton NMR and Carbon NMR spectra. Thermo 
Figure 2: Qualitative analysis of AEF 1 by HPTLC
Figure 3: Comparison of HPTLC spectrum of AEF 1 on differ-
ent tracks
Figure 4: I.R spectral analysis of AEF 1
Figure 5: 1H NMR spectra of AEF-1
AQ-1
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analysis of  the isolated compounds was carried out by 
DSC (Shimadzu). Finally the compounds were analyzed 
by LCMS SHIMADZU Spectrophotometer for deter-
mining their molecular weights and molecular formulae. 
However the entire compiled information was used for 
characterizing the compounds.9-11 
Molecular docking studies: 
Isolated compounds AEF 1 (Quercetin) and AEF 2.3 
(Betulin) were studied by in silico technique using auto-
mated docking software (v Life, Pune). A protein 2 ETE 
of  Oxalate oxidase was downloaded from pdb (www.rcsb.
org/pdb) which reportedly participate in kidney stone 
formation.
RESULTS 
Characterization of  Isolated Compounds compound 1: 
AEF 1
Physical Properties
The Color of  the isolated compound -1 was Yellowish; 
its physical state was solid, soluble in Methanol, Chlo-
roform and DMSO. The Melting Point was found to be 
315-317°C as determined by open capillary method and 
the Rf  value was 0.47 as determined by TLC method.
Spectral Data
The IR spectral data (cm-1) of  isolated compound AEF 
1 (KBR pellets technique) has revealed the vibrations at 
3406 (O-H), 1582 (C=C), C=O (1665). (Table 1)
The 1HNMR δ (DMSO) spectral data has revealed 
the proton signals at 6.38(1H, d, J=1.7Hz), 6.39 (1H, 
d, J=1.7Hz). Signals at δ = 6.88 (Ar 1H d, J=6.4Hz), 
7.68 (2H d, 2.5Hz) 9.37(1H-OH d, 2.2Hz), 10.7 (1H d, 
2Hz) 12.47(1H d, 2Hz). The 1HNMR spectrum showed 
characteristic protons at aromatic regions from 6–8 
ppm and strong hydrogen bonding at 12.5 ppm. (Figure 
5) These suggest the possibility of  Quercetin nucleus 
in the compound. The 13C-NMR spectra revealed 15 
carbon signals typical of  flavonoid nucleus (Quercetin 
nucleus). (Table 2, Figure 6)
The Thermo Analytical data was determined using 
DSC-60 (Shimadzu) for the compound and it has shown 
characteristic peaks at 3150C (Tm) (Figure 8).
LCMS has revealed m/z [M-H] + at 302 and other frag-
ment ions at 257(15), 228 (8), 201(8), 154(8), 136(9), 
110(9), 70 (4) and 23 (3). (Table 3, Figure 7)
The molecular formula was derived from the above 
LCMS data and it is C15H10O5
From the above analyses, the compound AEF 1 was 
identified as 2-(3,4 – dihydroxy  phenyl) -3,5,7-trihy-
droxy-4H-chromen-4-one (Quercetin). The structure 
of  the compound is 
Characterization of  Isolated Compound 2: AEF 2.3
Physical Properties
The color of  the isolated compound AEF 2.3 was Buff  
White, its physical state was solid, found to be soluble in 
Methanol and DMSO. The Melting Point was found to 
be 242-244°C (determined by open capillary method). 
The Rf  value was 0.53 as determined by TLC method.
Spectral Data
The IR spectral data (cm-1) of  isolated compound AEF 
2.3 (KBR pellet technique) has revealed the vibrations - 
O-H (3414), Ar-H (2943), C=O (1643). (Table 1, Figure 
4)













AEF 1 -3.92 -4.37 2 6
AEF 2.3 -3.72 -4.11 2 6
Table 1: I.R spectral data of isolated compounds
Compound Vibrations in cm-1
AEF 1 3406(O-H), 1582 (C=C), 1665 
(C=O)
AEF 2.3 3414( O-H), 2943( Ar-H) , 
1643( C=O)
Table 2: NMR Spectral data of isolated compounds
Compound Proton Carbon
AEF 1 6.38, 6.39, 6.88. 






AEF 2.3 1.1, 1.3, 1.4, 1.7, 
2.1. 2.3 , 2.46 , 3.0 
, 3.2 ,  3.8,  4.6 , 
4.68 , 4.75
40, 53, 55, 60, 71, 
106, 122
Table 3: LCMS Spectral data of isolated compounds
Compound Molecular ion( 
m/z)
Molecular formula
AEF1 302 (m+1) C15H10O5
AEF2.3 443 (m-1) C30H50O2
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The 1HNMR δ (DMSO) spectral data has revealed 
the proton signals at:  δ value 1.0-1.2 (t, 6H); 1.5-1.7 
(m, 15H); 2.1 (m, 2H); 2.91-3.0 (m,2H); 3.0 - 3.3 (d, 
7H);3.75 (d, 7H); 3.9-4 (d, 6H); 4.3 (s, 2H);4.5 (d, 3H) 
and it shows the presence of  50 hydrogens in the com-
pound. The C13 NMR Spectrum has shown the carbon 
peaks at 40, 53, 55, 60, 71, 106, and 122. (Table 2, Figure 
10).
Thermo Analytical study was carried out using DSC-60 
(Shimadzu) and it has shown characteristic sharp peak 
at 2400C (Tm).15 (Figure 14)
The LCMS has revealed [M+H] + at 443 and other frag-
ment ions at 413, 384, 246, 221, 193, 174 (Table 3, Fig-
ure 13).
The molecular formula was deduced for the compound 
AEF 2.3 based on LCMS spectra and it is -C30H50O2
From the above analyses, the compound was identified 
as Lup-20(29)-ene-3β, 28-diol (Lupeol). The structure 
of  the compound is11,12
Molecular docking results of  AEF 1 and AEF 2.3 using 
2 ETE of  Oxalate oxidase 16,
Compound 1: AEF 1 (Quercetin) and AEF 2.3 (Bet-
ulin) were subjected to in silico docking studies using 
Autodocking software and the enzyme 2 ETE of  Oxa-
late oxidase from pdb (www.rcsb.org/pdb). The docking 
results has shown that the binding strength of  AEF 1 
(Quercetin) in the active site of  the enzyme was -3.92 
kcal/mol, Docking energy -4.37 kcal/mol and six 
H-bonds were predicted between Quercetin and the 
enzyme. This indicates that Quercetin can act as a bet-
ter inhibitor of  the enzyme. (Table 4, Figure 9)
Docking results of  Compound 2: AEF 2.3 ( Betulin ): 
The docking results has shown that the binding strength 
of  AEF 2.3 (Betulin) in the active site of  the enzyme 
was -3.72 kcal/mol, Docking energy -4.11 kcal/mol and 
six H-bonds were predicted between Betulin and the 
enzyme. This indicates that Betulin can also be a better 
inhibitor of  the enzyme. (Table 4, Figure 15)
DISCUSSION
The herb Aerva lanata (L) was collected from West-
ern Ghats of  Belgaum region (India) and subjected to 
extraction with hydro alcohol. The crude extract was 
dried and fractionated with different solvents of  vary-
ing polarities such as Dichloromethane, ethylacetate and 
n-butanol with an objective of  isolating group of  active 
constituents. Based on the preliminary phytochemical 
investigations and spectral analysis, these two fractions 
(ethyl acetate and n-butanol) were later subjected to 
bioactivity guided isolation of  potent active constitu-
ents using column chromatography followed by pre-
parative TLC. Ethyl acetate and n-butanol have yielded 
two compounds, one from n-butanol (AEF 1) and two 
from ethyl acetate with almost closer Rf  values. These 
isolated compounds were characterized by using mod-
ern analytical techniques such I.R, HPTLC, 1 HNMR,13 
CNMR and LCMS.
The compound isolated from n-butanol (AEF 1) was 
characterized as Quercetin and the compounds isolated 
from ethyl acetate (AEF 2.3) was characterized as Betu-
lin. Compound 1 (AEF 1) was isolated as a yellow pow-
der.  The I.R spectrum of  the compound has shown 
characteristic peaks for the presence of  functional 
groups 3406 (O-H), 1582 (C=C), C=O (1665) which 
were characteristic of  flavanoids. The qualitative analy-
sis of  the compound by HPTLC has shown Rf  value at 
0.5 and the peak height was 40. The isolated compound 
AEF 1 was analyzed by DSC-60 Shimadzu for thermo 
analytical information and it has shown characteristic 
endothermic peak at 3150C (Melting, Temp Tm) which 
almost corresponds to the temp at which it melts com-
pletely. DSC analysis has shown sharp peaks which also 
provide information regarding purity of  the sample. 
The ESI-MS of  the compound gave a molecular ion 
peak [M-H] at m=z 302, compatible with the molecu-
lar formula C15H10O7. Its UV absorptions in MeOH 
were consistent with the presence of  pentahydroxyfla-
vone structure. In the 1H-NMR spectrum , the aromatic 
region exhibited an ABX system at  7.73 (1H, d, J=2.0 
Hz, H-20), 7.62 (1H, dd, J=2.0 and 7.5 Hz, H-60), and 
6.87 (1H, d, J=8.0 Hz, H-50) due to di-substitution of  
ring B and a typical meta-coupled pattern for H-6 and 
H-8 protons ( 6.17 and 6.37, d, J=2.0 Hz). The 13CNMR 
spectrum showed the presence of  15 aromatic carbon 
signals. 
From the ethyl acetate fraction complex spot was 
obtained which has yielded two compounds with almost 
close Rf  values. However it was later resolved into one 
compound Compound-2 (AEF 2.3). It was isolated as 
white powder (Rf  0.53). The thermo analytical data of  
AEF 2.3 as determined by DSC-60 Shimadzu has shown 
characteristic endothermic peaks at 215-220oC (Tm). The 
I.R spectrum of  the compound has shown the presence 
of  functional groups such as O-H (3414 cm-1), Ar-H 
(2943 cm-1), C=O (1643 cm-1) which are characteristic 
of  Triterpenoids. The ESI-MS of  the compound gave 
a molecular ion peak [M-H] at m=z 443 correspond-
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Figure 12 : HPTLC  Spectra of AEF 2.3
Figure 6: 13C NMR spectra of AEF-1
Figure 13: LCMS spectrum of AEF 2.3
Figure 7: LC – MS spectrum of AEF 1 
Figure 8: Thermo Analytical data of AEF 1 by DSC 
Figure 10: 1H NMR Spectrum of AEF 2.3
Figure 9: a) Predicted binding site of 2 ETE b) 2 ETE from 
PDB (energy minimized) C) Docking of the molecule (AEF 1)
a) b)
c)
Figure 11: 13C NMR  Spectrum of AEF 2.3
AQ-1
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Figure 14: Thermo analytical study by DSC
Figure 15: a) 2 ETE from PDB (energy minimized ) b) Predict-
ed binding site (2 ETE ) C) Docking of the molecule (AEF 2.3)
ing with the molecular formula C30H50O2. The 
1H NMR 
spectra of  compound exhibited resonances due to aro-
matic systems. In the 1HNMR system, it shows the pres-
ence of  50 hydrogens in the compound at 1.0-1.2 (t, 
6H); 1.5-1.7 (m, 15H); 2.1 (m, 2H); 2.91-3.0 (m, 2H); 
3.0 - 3.3 (d, 7H); 3.75 (d, 7H); 3.9-4 (d, 6H); 4.3 (s, 2H); 
4.5 (d, 3H). C13 NMR has shown characteristic carbons 
in spectrum.
Molecular docking studies 
Based on the in vivo study results of  Aerva lanata (L) 
extract and fractions for Antiurolithiatic activity, it 
was thought to study the isolated compounds AEF 1 
(Quercetin) and AEF 2.3 (Betulin) by in silico technique 
to support their in vivo activity. It was also thought that 
this study shall help to understand the mechanism of  
action of  the enzyme and the drug in the Urolithiasis. 
Automated docking software was used to determine the 
orientation of  inhibitors bound in the active site of  2 
ETE enzyme of  Oxalate oxidase which was found to be 
one of  the responsible factors for stone deposition. A 
Lamarckian genetic algorithm method was employed 
for this study. The docking of  legend molecules with 
2 ETE of  Oxalate oxidase which reportedly participate 
in kidney stone formation in patients, reveals that both 
the inhibitor compounds exhibited the binding with 
one or other amino acids with better regio-specificity 
in the active pockets, which is showed in Figure 9 and 
15. The protein structure file (PDB ID: 2 ETE) taken 
from PDB (www.rcsb.org/pdb) was edited by removing 
the hetero atoms, adding C-terminal oxygen.  Figure 9 
and 15 also shows the in silico active pocket prediction 
of  amino acids of  protein 2 ETE involved in binding 
with the legends obtained from PDB Theoretically all 
the molecules showed very good binding energy and 
docking energy ranging from -3.72 to -3.92  kJ/mol and 
- 4.11 to -4.37 kJ/mol respectively. Among the tested 
compounds, docking of  2 ETE  with AEF 1 and AEF 
2.3 revealed that its docking energy and binding energy 
(-4.11, -4.37 and -3.72, -3.92kJ/mol, respectively ) favor-
able for a good inhibitor of  2 ETE. These compounds 
AEF 1 and AEF 2.3 need to be screened for in-vivo 
Antiurolithiatic activity in future. Based on the above 
In silico study results it can be predicted that these two 
compounds may be active Antiurolithiatic agents which 
shall be due to inhibition of  enzyme 2 ETE of  Oxalate 
oxidase. 
CONCLUSION
The isolated compounds from two fractions n-butanol 
and ethyl acetate of  Aerva lanata (L) plant extract using 
column chromatography were characterized by modern 
analytical techniques such as IR, HPTLC, NMR and 
LCMS as Quercetin and Betulin. These two compounds 
were also studied by In silico technique downloading a 
protein 2 ETE of  Oxalate oxidase from PDB and docked 
with it. This has generated good docking scores which 
predicts good inhibitory activity on the enzyme which 
reportedly responsible for kidney stone formation and 
good candidates for better Antiurolithiatic activity.
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